Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Erin Strcula

Physician Assistant Belpre, OH Physician Assistant

NPI 1740257369 CMS profile 10698700

807 Farson St Ste 136, Ste 203, Belpre, OH 45714

Open in the dashboard

General payments

$105,912

536 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Erin Strcula of Belpre, OH is reported in the CMS Open Payments database as having received $105,912 across 536 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,847 73
2024 General $11,464 69
2023 General $22,187 109
2022 General $26,390 132
2021 General $37,023 153

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Erin Strcula
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Erin Strcula were reported at $8,847. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Erin Strcula Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $37,023 $132 $37–$438 $132
2022 $26,390 $155 $48–$522 $149
2023 $22,187 $167 $52–$557 $160
2024 $11,464 $178 $55–$600 $164
2025 $8,847 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. SI-BONE, Inc. $94,717 367 payments
  2. Abbott Laboratories $6,171 119 payments
  3. Medtronic, Inc. $2,692 10 payments
  4. Relievant Medsystems, Inc. $1,448 14 payments
  5. Boston Scientific Corporation $276 4 payments
  6. Vertos Medical, Inc. $177 2 payments
  7. DePuy Synthes Sales Inc. $113 6 payments
  8. Globus Medical, Inc. $90 3 payments
  9. Providence Medical Technology, Inc. $53 1 payment
  10. Davol Inc. $33 1 payment
  11. Other $141 9 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $66,095 79 payments
  2. Travel and Lodging $22,498 135 payments
  3. Food and Beverage $14,919 319 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,400 3 payments
Products named General payments · program years 2021–2025
  1. IFUSE IMPLANT $56,088 204 payments
  2. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $17,513 49 payments
  3. IFUSE IMPLANT SYSTEM sacroiliac joint dysfunction $14,184 41 payments
  4. SYNCHROMED $2,400 3 payments
  5. Intracept Pain $1,421 11 payments
  6. Intracept Pain $1,421 11 payments
  7. Intracept Pain $1,421 11 payments
  8. Intracept Pain $1,421 11 payments
  9. PROCLAIM Neuromodulation $1,314 21 payments
  10. PROCLAIM Structural Heart $1,260 7 payments
  11. Other $4,808 131 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

287

Median for Physician Assistant: 241

Drug cost

$2,310

Median for Physician Assistant: $4,110

Branded share of claims

24.7%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cyclobenzaprine Hcl Generic 55 $511
Mupirocin Generic 68 $444
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 49 $335
Baclofen Generic 12 $295
Gabapentin Generic 28 $215
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 22 $188
Tizanidine Hcl Generic 13 $182
Methylprednisolone Generic 22 $90
Meloxicam Generic 18 $50

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 55 billing codes

Paid by Medicare

$39,775

Medicare's payments for the services billed

Medicare patients

274

Average age 72

Services billed

703

160 women, 114 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 39%
Diabetes 38%
Ischemic heart disease 35%
Chronic kidney disease 32%
Osteoporosis 32%
COPD 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

536 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record